SALT LAKE CITY, Dec. 21, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and […]
– SLS009 Demonstrated Promising Efficacy in Phase 1 Study with 36.4% Clinical Response (ORR) in r/r Peripheral T-cell Lymphomas (PTCL); […]
SAN DIEGO, Dec. 21, 2023 (GLOBE NEWSWIRE) — DMK Pharmaceuticals Corporation (Nasdaq: DMK) (“DMK”), a commercial stage neuro-biotech company primarily […]
Roseland, NJ, Dec. 21, 2023 (GLOBE NEWSWIRE) — The NFT Gaming Company, Inc. (“NFTG” or the “Company”), a company developing […]
CULVER CITY, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail” or “the Company”), a leading, global […]
MISSISSAUGA, Ontario, Dec. 21, 2023 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, […]
FRANKLIN, Tenn., Dec. 21, 2023 (GLOBE NEWSWIRE) — Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”) a physician […]
MINNEAPOLIS, MN, US, Dec. 21, 2023 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company”), an emerging […]
Media Release SYDNEY, AUSTRALIA, Dec. 21, 2023 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), […]
PITTSBURGH, Dec. 21, 2023 (GLOBE NEWSWIRE) — L.B. Foster Company (NASDAQ: FSTR), a global technology solutions provider of products and […]
